Recursion is eliminating approximately 20% of its workforce, in a restructuring that reflects challenges seen across the biopharma industry.

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2025, the Compensation Committee of the Board ...

FBI and DEA operation in Atlanta leads to arrest of Harralson, seizing 33 firearms and drugs worth $9 million, including ...

Scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have made one of the most ...

In March, the journal Nature published the discoveries of two paradigm-breaking antimicrobial compounds in as many weeks: a ...

In JAMA, the FDA's Makary and Prasad said they will focus on modernizing review processes and lowering drug costs but don't outright mention precision medicine.

Acetaminophen may be doing more than just dulling pain in your brain it could be stopping it before it even starts. Scientists at Hebrew University have discovered that a metabolite of the drug, AM404 ...

Adaptive trials allow for modifications to be made during the trial without requiring additional approvals. According to the ...

Seek Labs?a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics?today announced BioSeekertm, a next-generation AI ...

Naples-based Enveric Biosciences secured a new U.S. patent for novel compounds targeting melatonin receptors, advancing drug development for sleep and mental health disorders.

Having previously identified a panel of candidate mRNA biomarkers with potential clinical relevance, Mainz Biomed will now begin the verification process in collaboration with Crown Bioscience, a ...

Law enforcement officials said they confiscated multiple dogs, an alligator, young raccoons and turtles that had been abused from a property they were investigating.